Martin Sprick

13PUBLICATIONS
89CO-AUTHORS
Molecular targetsTissue engineeringSolid tumoursCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 28, 2026
Neuroendocrine Differentiation Mediates Escape from HER2-Targeted Therapy in Breast Cancer.

|Dec 31, 2025
Validation of a UPLC-MS/MS Method for Quantifying Intracellular Olaparib Levels in Resistant Ovarian Cancer Cells.

Szymon W Kmiecik, Jennifer Lewis, Jonas Schwickert

|Sep 26, 2025
Proteomic Characterization Reveals CYP2S1 as a Mediator of Drug Resistance in PDAC.

Vera Thiel, Wiebke M Nadler, Alexander Kerner

|Feb 28, 2025
Biopsy-derived organoids in personalised early breast cancer care: Challenges of tumour purity and normal cell overgrowth cap their practical utility.

Paul Schwerd-Kleine, Roberto Würth, Tasneem Cheytan

|Feb 17, 2025
Characterization of single neurons reprogrammed by pancreatic cancer.

Vera Thiel, Simon Renders, Jasper Panten

|Jan 03, 2025
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1-HER3 signaling.

Roberto Würth, Elisa Donato, Laura L Michel

Pageof 3

Frequent Collaborators

6 joint publications

Andreas Trumpp

3 joint publications

Elisa Donato

3 joint publications

Matthias Schlesner

2 joint publications

Elisa Espinet